99mTc-labeled bombesin analog for breast cancer identification

Journal of Radioanalytical and Nuclear Chemistry

Volumn 295, Issue 3, 2013, Pages 2083-2090

  De Barros, André Luís Branco ^a   Das Graças Mota, Luciene ^a   De Aguiar Ferreira, Carolina ^a   Corrêa, Natássia Caroline Resende ^a   De Góes, Alfredo Miranda ^a   Oliveira, Mônica Cristina ^a   Cardoso, Valbert Nascimento ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bombesin; Breast tumor; Diagnosis; MDA MB 231; Radiolabeled peptide; Scintigraphic imaging

Indexed keywords

ACETOACETIC ACID DERIVATIVE; BOMBESIN DERIVATIVE; CHEMICAL COMPOUND; CYSTEINE; ETHYLENDIAMINEDIACETIC ACID; HYDRAZINONICOTINAMIDE BETA ALANINE BOMBESIN[7-14] TECHNETIUM 99M; LIGAND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TRICINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; LIVER; MOLECULAR STABILITY; MOUSE; MUSCLE; NONHUMAN; NUDE MOUSE; PLASMA; RECEPTOR AFFINITY; SPLEEN; URINARY EXCRETION;

EID: 84876283927     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-012-2331-8     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. de Barros ALB, Mota LG, Ferreira CA, Oliveira MC, Góes AM, Cardoso VN (2010) Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification. Bioorg Med Chem Lett 10:6182-6184
3. Dijkgraaf I, Rijnders AY, Soede A, Dechesne AC, van Esse GW, Brouwer AJ, Corstens FHM, Boerman OC, Rijkers DTS, Liskamp RMJ (2007) Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org Biomol Chem 5:935-944
4. Froidevaux S, Eberle AN, Christe M, Sumanovski L, Heppeler A, Schmitt JS, Eisenwiener K, Beglinger C, Macke HR (2002) Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model. Int J Cancer 98:930-937
5. Froidevaux S, Heppeler A, Eberle AN, Meier A, Hausler M, Beglinger C, Béthé M, Powell P, Macke HR (2000) Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1, 4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy. Endocrinology 141:3304-3312
6. 3-Octreotide: first results in patients with meningiomas. J Nucl Med 42:1053-1056
7. Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC, Maecke HR (2004) Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with Indium-111, Lutetium-177, and Yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res 64:6707-6715
8. Munnink THO, Nagengast WB, Brouwers AH, Schroder CP, Hospers GA, Lub-de Hooge MN, Van der Wall E, Van Diest PJ, Vries EGE (2009) Molecular imaging of breast cancer. Breast J S3:S66-S73
9. Schottelius M, Wester H (2009) Molecular imaging targeting peptide receptors. Methods 48:161-177
10. Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ (2008) Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl Med Biol 35:401-411
11. Koopmans KP, Neels ON, Kema IP, Elsinga PH, Links TP, Vries EGE, Jager PL (2009) Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results. Crit Rev Oncol Hematol 71:199-213
12. Okarvi SM, Al-Jammaz I (2003) Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent. Anticancer Res 23:2745-2750
13. Santos-Cuevas CL, Ferro-Flores G, Merphy CA, Ramírez FM, Luna-Gutiérrez MA, Pedraza-Lopez M, Gárcia-Becera R, Ordaz-Rosado D (2009) Design, preparation, in vitro and in vivo evaluation of 99mTc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Int J Pharm 375:75-83
14. Virgolini IJ, Gabriel M, Guggenberg EV, Putzer D, Kendler D, Decristoforo C (2009) Role of radiopharmaceutical in the diagnosis and treatment of neuroendocrine tumours. Eur J Cancer 45:274-291
15. Zhang K, Aruva MR, Shanthly N, Cardi CA, Patel CA, Rattan S, Cesarone G, Wickstrom E, Thakur ML (2007) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: in vitro/in vivo evaluation. Regul Pept 144:91-100
16. Anastasi A, Erspamer V, Bucci M (1971) Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166-167
17. Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389-427
18. Jensen RT, Battley JF, Spindel ER, Benya RV (2008) Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42
19. Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
20. Smith CJ, Volkert WA, Hoffman TJ (2005) Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Nucl Med Biol 32:733-740
21. Schulz S, Rocken C, Schulz S (2006) Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies. Virchows Arch 449:421-427
22. Weber HC (2009) Regulatory and signaling of human bombesin receptor and their biological effects. Curr Opin Endocrinol Diabetes Obes 16:66-71
23. Langer M, Beck-Sickinger AG (2010) Peptides as carrier for tumor diagnosis and treatment. Curr Med Chem Anticancer Agents 1:71-93
24. Schuhmacher J, Zhang H, Doll J, Macke HR, Matys R, Hauser H, Henze M, Haberkorn U, Eisenhut M (2005) GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68 Ga-labeled bombesin(6-14) analog. J Nucl Med 46:691-699
25. Scopinaro F, de Vincentis AD, Varvarigou AD (2005) Use of radiolabeled bombesin in humans. J Clin Oncol 23:3170-3171
26. van de Wiele C, Phonteyne P, Pauwels P, Goethals I, Van den Broecke R, Cocquyt V, Dierckx RA (2008) Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry. J Nucl Med 49:260-264
27. Hoffman TJ, Quinn TP, Volkert WA (2001) Radiometalled receptor-avid peptide conjugates for specific in vivo targeting of cancer cells. Nucl Med Biol 28:527-539
28. 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med 44:823-831
29. Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ (2007) Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: syntesis, radiolabeling, and in vitro/in vivo studies. Bioconjug Chem 18:1651-1661
30. 64Cu-labeled RGD-bombesin heterodimer. J Nucl Med 50:1168-1177
31. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 47:492-501
32. de Barros ALB, Cardoso VN, Mota LG, Alves RJ (2010) Synthesis and biodistribution studies of carbohydrate derivative radiolabeled with technetium-99m. Bioorg Med Chem Lett 20:315-317
33. 99mTc-ECDG targeted at the multifunctional glucose system: feasibility studies with rodents. Radiology 226:465-473
34. 99mTc radiolabeling. J Med Chem 50:1418-1422
35. Miranda-Olvera AD, Ferro-Flores G, Pedraza-López M, Murphy CA, León-Rodríguez LM (2007) Synthesis of oxytocin HYNIC derivative as potent diagnostic agent for breast cancer. Bioconjug Chem 18:1560-1567
36. Zhang K, Aruva MR, Shanthly N, Cardi CA, Rattan S, Patel C, Kim C, McCue PA, Wickstrom E, Thakur ML (2008) PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med 49:112-121
37. 99mTc-N3S-X-BBN[7-14]NH2: an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8- and 11-carbon tethering moieties. Bioconjug Chem 14:93-102
38. Kim I, Kim TH, Ma K, Park ES, Oh KT, Lee ES, Lee KC, Youn YS (2011) A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action. Regul Pept 167:239-245
39. 99mTc]Domobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging. Eur J Nucl Med Mol Imaging 30:247-258
40. Chao C, Ives K, Hellmich HL, Townsend CM, Hellmich MR (2009) Gastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression. J Surg Res 156:26-31
41. Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, Reubi JC (2008) Bombesin receptor antagonists may be preferable to agonists for tumor targeting. J Nucl Med 49:318-326
42. Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi J, Maecke HR (2005) Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. J Nucl Med 46:823-830
43. Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi JC, Maecke HR (2011) Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging 38:97-107
44. Halmos G, Wittliff JL, Schally AV (1995) Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res 55:280-287
45. Phillips WT (1999) Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 37:13-32